Table 1.
Relationship between hsa_circRNA_100855 expression and clinicopathological features of LSCC
| Characteristics (n) | hsa_circRNA_100855 level | P |
|---|---|---|
| Gender | 0.113 | |
| Male (37) | 10.095±3.385 | |
| Female (15) | 11.451±3.632 | |
| Age | 0.121 | |
| ≥ 58 (26) | 9.918±3.287 | |
| < 58 (26) | 11.054±3.632 | |
| T classification | 0.006 | |
| T1-2 (32) | 9.468±2.906 | |
| T3-4 (20) | 12.114±3.761 | |
| Differentiation | 0.487 | |
| G1 (35) | 10.467±2.045 | |
| G2 (17) | 10.495±4.021 | |
| Lymph node metastasis | 0.003 | |
| Negative (34) | 9.403±2.622 | |
| Positive (18) | 12.531±4.019 | |
| Primary location | 0.007 | |
| Supraglottis (23) | 11.846±3.811 | |
| Glottis (29) | 9.407±2.810 | |
| Clinical stage | 0.001 | |
| I-II (31) | 9.230±2.614 | |
| III-IV (21) | 12.341±3.810 |